Document Detail


The impact of asthma medication guidelines on asthma controller use and on asthma exacerbation rates comparing 1997-1998 and 2004-2005.
MedLine Citation:
PMID:  22192958     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: The relationship between asthma controller medication use and exacerbation rates over time is unclear at the population level.
OBJECTIVE: To estimate the change in asthma controller medication use between 2 time periods as measured by the controller-to-total asthma medication ratio and its association with changes in asthma exacerbation rates between 1997-1998 and 2004-2005.
METHODS: The study design was a cross-sectional population-level comparison between individuals from 1997-1998 and 2004-2005. Study participants were individuals aged 5 to 56 years identified as having asthma in the Medical Expenditure Panel Survey (MEPS). The main outcome measures were a controller-to-total asthma medication ratio greater than 0.5 and asthma exacerbation rates (dispensing of systemic corticosteroid or emergency department visit/hospitalization for asthma) in 1997-1998 compared with 2004-2005.
RESULTS: The proportion of individuals with a controller-to-total asthma medication ratio greater than 0.5, when adjusted for other demographic factors, has improved by 16.1% (95% CI: 10.8%, 21.3%) for all individuals from 1997-1998 to 2004-2005. Annual asthma exacerbation rates did not change significantly in any group from 1997-1998 to 2004-2005 (0.27/year to 0.23/year). African American and Hispanic individuals with asthma had higher asthma exacerbation rates and a lower proportion with a controller-to-total asthma medication ratio greater than 0.5 than whites in both 1997-1998 and 2004-2005; however, these differences were not statistically significant.
CONCLUSIONS: An increase in asthma controller-to-total medication ratio in a sample reflective of the US population was not associated with a decreased asthma exacerbation rate comparing 1997-1998 and 2004-2005.
Authors:
Matthew A Rank; Juliette T Liesinger; Jeanette Y Ziegenfuss; Megan E Branda; Kaiser G Lim; Barbara P Yawn; Nilay D Shah
Related Documents :
21919068 - Retrospective analysis of 55,769 hba1c eqa results obtained from professional laborator...
25202688 - A proposal for clinical genetics (genetics in medicine) education for medical technolog...
1866538 - Peritonitis due to prototheca wickerhamii in a patient undergoing chronic ambulatory pe...
1755678 - Bronchopleural fistula after stapled closure of bronchus.
9227668 - Selection of an antidepressant: mirtazapine.
3990388 - Career preferences under conditions of medical unemployment. the case of interns in mex...
Publication Detail:
Type:  Journal Article     Date:  2011-11-02
Journal Detail:
Title:  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology     Volume:  108     ISSN:  1534-4436     ISO Abbreviation:  Ann. Allergy Asthma Immunol.     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2011-12-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9503580     Medline TA:  Ann Allergy Asthma Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  9-13     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Affiliation:
Division of Allergic Diseases, Olmsted Medical Center, Rochester, MN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bioactive food components prevent carcinogenic stress via Nrf2 activation in BRCA1 deficient breast ...
Next Document:  Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease.